Unilever R&D clinical trials
Unilever R&D is the lead sponsor of 3 current clinical trials in our USA, India and China registers. 1 is recruiting patients now. All registered phases are Not applicable. The most-studied condition is Skin Brightening.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Unilever R&D
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
The Effect of Cosmetic Formulations on the Appearance of Grey Hair.
NCT07280676 · ClinicalTrials.gov ↗ · Hair Graying
|
Not applicable | Recruiting | 2025-12 | USA |
|
The Effect of Cosmetic Products on Skin Brightening
NCT06899321 · Skin Brightening
|
Not applicable | Not yet open | 2025-03 | India |
|
An Exploratory Study to Evaluate Skin Brightening Effects of Different Cosmetic Formulations on UV Irradiated Tanning Model
NCT07795866 · ClinicalTrials.gov ↗ · Skin Brightening
|
Not applicable | Active, closed | 2026-09 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Unilever R&D trials
2 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 1 | 1 |
| Clinical trials in India | 1 | 0 |
| Clinical trials in China | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Questions about Unilever R&D trials
How many clinical trials does Unilever R&D sponsor?
Unilever R&D is the lead sponsor of 3 current trials on ClinicalTrials.gov in our USA, India and China registers, as of the registry sync on 21 October 2026. Completed and withdrawn studies are not counted.
Are Unilever R&D trials recruiting?
Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 21 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.